China Life Private Equity Investment

China Life Private Equity Investment

Shanghai, Shanghaiclpe.com.cn

Overview

China Life Private Equity Investment Co., Ltd. is the professional private equity investment platform under the China Life Group, established in June 2016. The firm focuses on long-term value investing and manages funds, including the flagship China Life Healthcare Fund. Its primary investment areas are healthcare (including life sciences, med-tech, and digital health) and technology (including AI and semiconductors). The firm is registered in the Shanghai Free Trade Zone and is an active investor in the Chinese market.

Year Founded

2016

Portfolio Companies

5

Investments

CompanyDateStageLead
Cascade Pharmaceuticals, Inc.Feb 2026Early FundingCo-investor
Jiangsu Vcare PharmatechJan 2024Series CLead
HithiumJun 2023Series CLead
Xi'an Eswin Material Technology Co., Ltd.Dec 2022Series CCo-investor
Xi'an Eswin Material Technology Co., Ltd.Jul 2021Series BCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersShanghai, Shanghai
Year Founded2016

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.